Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells

Neoplasia (United States)

Volumn 14, Issue 12, 2012, Pages 1236-1248

  Beghini, Alessandro ^a   Corlazzoli, Francesca ^a   Del Giacco, Luca ^a   Re, Matteo ^a   Lazzaroni, Francesca ^a   Brioschi, Matteo ^b   Valentini, Giorgio ^a   Ferrazzi, Fulvia ^c,d   Ghilardi, Anna ^a   Righi, Marco ^a,e   Turrini, Mauro ^f   Mignardi, Marco ^g,h   Cesana, Clara ^f   Bronte, Vincenzo ⁱ   Nilsson, Mats ^g,h   Morra, Enrica ^f   Cairoli, Roberto ^f,j  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MUNICH   (Germany)

^e CNR   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g UPPSALA UNIVERSITY   (Sweden)

^h STOCKHOLM UNIVERSITY   (Sweden)

ⁱ VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^j VALDUCE HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; LUCIFERASE; MESSENGER RNA; STEM CELL FACTOR RECEPTOR; WNT10B PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW BIOPSY; CELL REGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE EXPRESSION; GENE REGULATORY NETWORK; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; WNT SIGNALING PATHWAY; ZEBRA FISH;

EID: 84871533176     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121480     Document Type: Article

References (60)

1. Cozzio A, Passegué E, Ayton PM, Karsunky H, Cleary ML, and Weissman IL (2003). Similar MLL-associated leukemias arising from self-renewing stem cellsand short-lived myeloid progenitors. Genes Dev 17, 3029-3035.
2. Somervaille TC, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM, Chang HY, Shurtleff SA, Downing JR, and Cleary ML (2006). Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4, 129-140.
3. Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H, Kurz E, Theilgaard-Mönch K, Månsson R, Pedersen TA, Pabst T, et al. (2008). Modelingof C/EBPα mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 13, 299-310.
4. Bereshchenko O, Mancini E, Moore S, Bilbao D, Månsson R, Luc S, Grover A, Jacobsen SE, Bryder D, and Nerlov C (2009). Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPα mutant AML. Cancer Cell 16, 390-400.
5. Beachy PA, Karhadkar SS, and Berman DM (2004). Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324-331.
6. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, et al. (2009). Genetic interactionof PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136, 1136-1147.
7. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, et al. (2009). Hedgehog signalling is essentialfor maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776-779.
8. Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH, Kharas MG, Miller PG, Cornejo MG, Okabe R, et al. (2009). Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 4, 559-567.
9. Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, Lillington D, Oakervee H, Cavenagh J, Agrawal SG, et al. (2008). Anti-CD38antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112, 568-575.
10. Goardon N, Marchi E, Atzberger A, Quek L, Schuh A, Soneji S, Woll P, Mead A, Alford KA, Rout R, et al. (2011). Coexistence of LMPP-like and GMP-likeleukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138-152.
11. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, and Buck DW (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002-5012.
12. Mizrak D, Brittan M, and Alison MR (2007). CD133: molecule of the moment. J Pathol 214, 3-9.
13. Congdon KL, Voermans C, Ferguson EC, DiMascio LN, Uqoezwa M, Zhao C, and Reya T (2008). Activation of Wnt signaling in hematopoietic regeneration. Stem Cells 26, 1202-1210.
14. Katoh M and Katoh M (2006). Cross-talk of WNT and FGF signaling path-ways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer BiolTher 5, 1059-1064.
15. Larsson C, Grundberg I, Söderberg O, and Nilsson M (2010). In situ detectionand genotyping of individual mRNA molecules. Nat Methods 7, 395-397.
16. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al. (1992). RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
17. Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R, Chiang JH, Hood L, Clarke MF, and Weissman IL (2009). Dysregulated gene expression networksin human acute myelogenous leukemia stem cells. Proc Natl Acad Sci USA 106, 3396-3401.
18. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, and Weissman IL (2003). A role for Wnt signalling in self-renewalof haematopoietic stem cells. Nature 423, 409-414.
19. Staal FJT and Luis TC (2010). Wnt signaling in hematopoiesis: crucial factors forself-renewal, proliferation, and cell fate decisions. J Cell Biochem 109, 844-849.
20. Mikesch JH, Steffen B, Berdel WE, Serve H, and Müller-Tidow C (2007). Theemerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 21, 1638-1647.
21. Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, and Armstrong SA (2010). The Wnt/β-catenin pathway is required for thedevelopment of leukemia stem cells in AML. Science 327, 1650-1653.
22. Scheller M, Huelsken J, Rosenbauer F, Taketo MM, Birchmeier W, Tenen DG, and Leutz A (2006). Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation. Nat Immunol 7, 1037-1047.
23. Kirstetter P, Anderson K, Porse BT, Jacobsen SE, and Nerlov C (2006). Acti-vation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 7, 1048-1056.
24. Smith ML, Hills RK, and Grimwade D (2011). Independent prognostic vari-ables in acute myeloid leukaemia. Blood Rev 25, 39-51.
25. Brioschi M, Fischer J, Cairoli R, Rossetti S, Pezzetti L, Nichelatti M, Turrini M, Corlazzoli F, Scarpati B, Morra E, et al. (2010). Down-regulation of micro-RNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits. Neoplasia 12, 866-876.
26. Falcon S and Gentleman R (2007). Using GOstats to test gene lists for GOterm association. Bioinformatics 23(2), 257-258.
27. Huang DW, Sherman BT, and Lempicki RA (2009). Systematic and integrativeanalysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1), 55-57.
28. Hatta K and Takahashi Y (1996). Secondary axis induction by heterospecificorganizers in zebrafish. Dev Dyn 205, 183-195.
29. Thisse C, Thisse B, Schilling TF, and Postlethwait JH (1993). Structure of thezebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutantembryos. Development 119, 1203-1215.
30. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, and Nolta JA (2006). Selection based on CD133 and high aldehydedehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107, 2162-2169.
31. Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Y, andFurukawa Y (2006). Enhanced SMYD3 expression is essential for the growth ofbreast cancer cells. Cancer Sci 97, 113-118.
32. Mao B and Niehrs C (2003). Kremen2 modulates Dickkopf2 activity duringWnt/LRP6 signaling. Gene 302, 179-183.
33. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, and Wells JM (2007). Sox17 and Sox4 differentially regulate β-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Moll Cell Biol 27, 7802-7815.
34. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, et al. (2006). Homeodomain-mediatedβ-catenin-dependent switching events dictate cell-lineage determination. Cell 125, 593-605.
35. Mieszczanek J, de la Roche M, and Bienz M (2008). A role of Pygopus as ananti-repressor in facilitating Wnt-dependent transcription. Proc Natl Acad SciUSA 105, 19324-19329.
36. Gu B, Sun P, Yuan Y, Moraes RC, Li A, Teng A, Agrawal A, Rhéaume C, Bilanchone V, Veltmaat JM, et al. (2009). Pygo2 expands mammary pro-genitor cells by facilitating histone H3 K4 methylation. J Cell Biol 185, 811-826.
37. Gehrke I, Gandhirajan RK, and Kreuzer KA (2009). Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: multiplicity oftherapeutic options. Eur J Cancer 45, 2759-2767.
38. Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, MacCoss MJ, andMoon RT (2006). The KLHL12-Cullin-3 ubiquitin ligase negatively regulatesthe Wnt-β-catenin pathway by targeting Dishvelled for degradation. Nat Cell Biol 8, 348-357.
39. Li Y, Lu W, King TD, Liu CC, Bijur GN, and Bu G (2010). Dkk1 stabilizes Wntco-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PloS One 5, e11014.
40. Wang K, Zhang Y, Li X, Chen L, Wang H, Wu J, Zheng J, and Wu D(2008). Characterization of the Kremen-binding site on Dkk1 and elucidationof the role of Kremen in Dkk-mediated Wnt antagonism. J Biol Chem 22, 23371-23375.
41. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Näär AM, and Dyson NJ (2008). E2F1 represses β-catenin transcriptionand is antagonized by both pRB and CDK8. Nature 25, 552-556.
42. Gao X, Wen J, Zhang L, Li X, Ning Y, Meng A, and Chen YG (2008). Dapper1 isa nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus. J Biol Chem 283, 35679-35688.
43. Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, and Yee AS (2001). Negative regulation of the Wnt-β-catenin path-way by the transcriptional repressor HBP1. EMBO J 20, 4500-4511.
44. Quéré R, Andradottir S, Brun AC, Zubarev RA, Karlsson G, Olsson K, Magnusson M, Cammenga J, and Karlsson S (2011). High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event. Leukemia 25, 515-526.
45. Bowman TV, Tropouki E, and Zon LI (2012). Linking hematopoietic regenera-tion to developmental signaling pathways: a story of BMP and Wnt. Cell Cycle 11, 424-425.
46. Staal FJ, Noort Mv M, Strous GJ, and Clevers HC (2002). Wnt signals aretransmitted through N-terminally dephosphorylated β-catenin. EMBO Rep 31,63-68.
47. Lin X, Rinaldo L, Fazly AF, and Xu X (2007). Depletion of Med10 enhancesWnt and suppresses Nodal signaling during zebrafish embryogenesis. Dev Biol303, 536-548.
48. Langdon YG and Mullins MC (2011). Maternal and zygotic control of zebrafishdorsoventral axial patterning. Annu Rev Genet 45, 357-377.
49. Schier AF (2003). Nodal signaling in vertebrate development. Annu Rev Cell DevBiol 19, 589-621.
50. Siapati EK, Papadaki M, Kozaou Z, Rouka E, Michali E, Savvidou I, Gogos D, Kyriakou D, Anagnostopoulos NI, and Vassilopoulos G (2010). Proliferationand bone marrow engraftment of AML blasts is dependent on β-catenin signaling. Br J Haematol 152, 164-174.
51. Fauth F, Weidmann E, Martin H, Schneider B, Sonnhoff S, and Hoelzer D(2001). AC133 expression on acute myeloid leukemia blasts: correlation to FABand to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML. Leuk Res 25(3), 191-196.
52. Austin TW, Solar GP, Ziegler FC, Liem L, and Matthews W (1997). A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitorcells. Blood 89, 3624-3635.
53. + cells with cancer stem cell characteristics. Breast Cancer Res 10, 1-16.
54. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, and Dick JE (2006). Targeting of CD44eradicates human acute myeloid leukemic stem cells. Nat Med 12, 1167-1174.
55. Angers S and Moon RT (2009). Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10, 468-477.
56. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N, et al. (2005). Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6(3), 314-322.
57. Mödder UI, Oursler MJ, Khosla S, and Monroe DG (2011). Wnt10b activates the Wnt, Notch and NFκB pathways in U2OS osteosarcoma cells. J Cell Biochem112(5), 1392-1402.
58. Trompouki E, Bowman TV, Lawton LN, Fan ZP, Wu DC, DiBiase A, Martin CS, Cech JN, Sessa AK, Leblanc JL, et al. (2011). Lineage regulators directBMP and WNT pathways to cell-specific programs during differentiation and regeneration. Cell 147, 577-589.
59. Lu FI, Thisse C, and Thisse B (2011). Identification and mechanism of regulation of the zebrafish dorsal determinant. Proc Natl Acad Sci USA 108,15876-15880.
60. Hashiguchi M, Shinya M, Tokumoto M, and Sakai N (2008). Nodal/Bozozokindependent induction of the dorsal organizer by zebrafish cell lines. Dev Biol 321, 387-396.